Now Enrolling!
LP(a) trial study
Research shows that 20% of the world population is affected with LP(a). LP(a) is a lipoprotein that can be elevated in some individuals leading to an increased risk for cardiovascular diseases. LP(a) is genetically determined, meaning that its levels are largely determined by your genes, specifically the LPA gene. As of right now, managing LP(a) levels presents a challenge in clinical practice. Join our clinical study to help and support others in taking charge of cardiovascular health.
Get started now
Have LP(a)≥175 nmol/L
≥18 with established ASCVD, with an event or revascularization ≥ 90 days.
≥55 years old with documented CAD or PAD or family history of high cholesterol.
≥70 years old(Female)/ ≥65 years old(Male) who has multiple cardiovascular risk factors.
Who is it for?
Testing & lab work at no cost
If you qualify, you may be compensated for time and travel